CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM)

Stem Cell Res. 2021 May:53:102256. doi: 10.1016/j.scr.2021.102256. Epub 2021 Feb 18.

Abstract

Arrhythmogenic cardiomyopathy (ACM) is characterized by fibro-fatty replacement of the myocardium, heart failure and life-threatening ventricular arrhythmias. Causal mutations were identified in genes encoding for proteins of the desmosomes, predominantly plakophilin-2 (PKP2) and desmoglein-2 (DSG2). We generated gene-edited knock-out iPSC lines for PKP2 (JMUi001-A-2) and DSG2 (JMUi001-A-3) using the CRISPR/Cas9 system in a healthy control iPSC background (JMUi001-A). Stem cell-like morphology, robust expression of pluripotency markers, embryoid body formation and normal karyotypes confirmed the generation of high quality iPSCs to provide a novel isogenic human in vitro model system mimicking ACM when differentiated into cardiomyocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CRISPR-Cas Systems / genetics
  • Cardiomyopathies* / genetics
  • Desmoglein 2 / genetics
  • Desmoglein 2 / metabolism
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Mutation
  • Myocytes, Cardiac / metabolism
  • Plakophilins / genetics

Substances

  • DSG2 protein, human
  • Desmoglein 2
  • PKP2 protein, human
  • Plakophilins